Stay updated on Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The study record dates have been updated to include new entries (2026-05-01, 2027-02-25, 2026-04-17, 2026-04) and remove earlier entries (2025-05-07, 2026-03-25, 2025-04-29, 2025-04), reflecting adjustments to the posting and QC timeline on the page.
    Difference
    0.2%
    Check dated 2026-05-03T01:20:23.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page version/build indicator was updated from v3.5.2 to v3.5.3, reflecting a minor administrative release rather than a substantive change to the trial’s study details.
    Difference
    0.0%
    Check dated 2026-04-25T18:39:53.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:33:58.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    - Updated page revision from v3.4.3 to v3.5.0. This appears to be an administrative update and does not modify study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-03-21T01:21:18.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 as part of a site update. This change does not modify study information or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-03-06T18:48:10.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 as a minor metadata update with no changes to study content or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:51:40.000Z thumbnail image

Stay in the know with updates to Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page.